Adaptimmune Therapeutics PLC (OTC:ADAPY) IPO

Adaptimmune Therapeutics PLC

IPO

Priced at US$17.00 an ADS on May 5, 2015.

Price
US$17.00 an ADS
ADSs offered
11,250,000 American depositary shares
Offering size
US$191.3 million
Underwriters' option
Up to 1,687,500 more ADSs
Listing
ADAP on the Nasdaq Global Select Market
Underwriters
BofA Merrill Lynch, Cowen and Company, Leerink Partners, Guggenheim Securities · In the order on the cover
ADSs delivered
On or about May 11, 2015

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 5, 2015
Filed publiclyApr 6, 2015
Amended twiceNewest May 1, 2015
Shares registered with an exchangeApr 30, 2015
Declared effective by the SECMay 5, 2015
Final prospectus, with the priceMay 7, 2015

From the cover of the final prospectus (424B4) filed May 7, 2015